Metabolomic signature between diabetic and non-diabetic obese patients: A protocol for systematic review.

Metabolomic signature between diabetic and non-diabetic obese patients: A protocol for systematic review.

Show other versions (1)

<h4>Background</h4>Type 2 diabetes mellitus (T2DM) is a chronic and progressive condition defined by hyperglycemia caused by abnormalities in insulin production, insulin receptor sensitivity, or both. Several studies have revealed that higher body mass index (BMI) is associated with incr...

Full description

Bibliographic Details
Main Authors:	Yuxing Tai, Xiaoqian Yang, Xiaochao Gang, Zhengri Cong, Sixian Wang, Peizhe Li, Mingjun Liu
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2024-01-01
Series:	PLoS ONE
Online Access:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0296749&type=printable

Similar Items

Metabolomic signature between diabetic and non-diabetic obese patients: A protocol for systematic review
by: Yuxing Tai, et al.
Published: (2024-01-01)

The effect of therapeutic massage on patients with obesity: A systematic review and meta-analysis
by: Zhengri Cong, et al.
Published: (2024-04-01)

Global research trends in regulating gut microbiome to improve type 2 diabetes mellitus: bibliometrics and visual analysis
by: Rongsheng Jiang, et al.
Published: (2024-06-01)

Identification of potential biomarkers and drug of ischemic stroke in patients with COVID-19 through machine learning
by: Sixian Wang, et al.
Published: (2024-10-01)

Identification of hub genes and candidate herbal treatment in obesity through integrated bioinformatic analysis and reverse network pharmacology
by: Yuxing Tai, et al.
Published: (2022-10-01)

Gene signature for prognosis in comparison of pancreatic cancer patients with diabetes and non-diabetes
by: Mingjun Yang, et al.
Published: (2020-11-01)

Genomics and Metabolomics in Obesity and Type 2 Diabetes
by: Adam Kretowski, et al.
Published: (2016-01-01)

Markers for obese and non-obese Type 2 diabetes identified using whole blood metabolomics
by: Takayuki Teruya, et al.
Published: (2023-02-01)

Metabolomic Signature Between Metabolically Healthy Overweight/Obese and Metabolically Unhealthy Overweight/Obese: A Systematic Review
by: Cheng D, et al.
Published: (2021-03-01)

Dietary patterns, metabolomic profile, and nutritype signatures associated with type 2 diabetes in women with postgestational diabetes mellitus: MyNutritype study protocol
by: Hasbullah, Farah Yasmin, et al.
Published: (2022)

Dietary Patterns, Metabolomic Profile, and Nutritype Signatures Associated with Type 2 Diabetes in Women with Postgestational Diabetes Mellitus: MyNutritype Study Protocol
by: Farah Yasmin Hasbullah, et al.
Published: (2022-09-01)

Metabolomic Signature of Coronary Artery Disease in Type 2 Diabetes Mellitus
by: Bernd Stratmann, et al.
Published: (2017-01-01)

Metabolomic signatures of Ramadan diurnal intermittent fasting in type 2 diabetes mellitus
by: Tahmina Akter, et al.
Published: (2024-03-01)

Metabolomics Signature in Prediabetes and Diabetes: Insights From Tandem Mass Spectrometry Analysis
by: Saad Ayyal Jabbar Al‐Rikabi, et al.
Published: (2024-05-01)

Serum metabolomic signatures of gestational diabetes in South Asian and white European women
by: Russell J de Souza, et al.
Published: (2022-04-01)

Untargeted metabolomic profiling reveals molecular signatures associated with type 2 diabetes in Nigerians
by: Ayo P. Doumatey, et al.
Published: (2024-03-01)

Identification of serum metabolome signatures associated with retinal and renal complications of type 2 diabetes
by: Yoshihiko Tomofuji, et al.
Published: (2023-01-01)

Gut microbiome signatures associated with type 2 diabetes in obesity in Mongolia
by: Akari Shinoda, et al.
Published: (2024-06-01)

Barriers and facilitators to yoga for obesity, diabetes, and hypertension: A qualitative systematic review protocol
by: Kaushik Chattopadhyay, et al.
Published: (2023-01-01)

Plasma Metabolome and Lipidome Associations with Type 2 Diabetes and Diabetic Nephropathy
by: Yan Ming Tan, et al.
Published: (2021-04-01)

Leptin Concentrations in Non-Obese and Obese Non-Diabetes Nigerian-Africans
by: Agbogu-Ike OU, et al.
Published: (2021-12-01)

Comparitive Study of Serum Leptin Levels in Diabetic Obese Patients and Non-Diabetic Obese Individuals
by: M Afkhami-Ardakani, et al.
Published: (2004-07-01)

Metabolomic signature of pediatric diabetic ketoacidosis: key metabolites, pathways, and panels linked to clinical variables
by: Paolo Spagnolo, et al.
Published: (2024-12-01)

Dietary alleviation of maternal obesity and diabetes: increased resistance to diet-induced obesity transcriptional and epigenetic signatures.
by: Linda Attig, et al.
Published: (2013-01-01)

Metabolic signatures of insulin resistance in non-diabetic individuals
by: Babak Arjmand, et al.
Published: (2022-08-01)

The influence of diabetes mellitus and obesity on upper limb arthroplasty outcomes: a systematic review protocol
by: Theodoulou, A, et al.
Published: (2017)

Metabolomic Signature of Diabetic Kidney Disease in Cerebrospinal Fluid and Plasma of Patients with Type 2 Diabetes Using Liquid Chromatography-Mass Spectrometry
by: Huan-Tang Lin, et al.
Published: (2022-10-01)

Metabolomic Profiling of Adipose Tissue in Type 2 Diabetes: Associations with Obesity and Insulin Resistance
by: Argyri Mathioudaki, et al.
Published: (2024-07-01)

Saliva, Plasma, and Multifluid Metabolomic Signatures of Periodontal Disease, Type 2 Diabetes Progression, and Markers of Glycemia and Dyslipidemia Among Puerto Rican Adults With Overweight and Obesity
by: Zicheng Wang, et al.
Published: (2024-08-01)

Effect of weight loss interventions on metabolomic signatures in obese children with insulin resistance
by: Xiaoguang Liu, et al.
Published: (2024-08-01)

Lipidomic and Metabolomic Signature of Progression of Chronic Kidney Disease in Patients with Severe Obesity
by: Borja Lanzon, et al.
Published: (2021-12-01)

Metabolomic Signatures for the Effects of Weight Loss Interventions on Severe Obesity in Children and Adolescents
by: Min-Ji Sohn, et al.
Published: (2021-12-01)

Metabolome and transcriptome signatures shed light on the anti-obesity effect of Polygonatum sibiricum
by: Xiaobin Ou, et al.
Published: (2023-04-01)

Serum metabolomics signature of maternally inherited diabetes and deafness by gas chromatography–time of flight mass spectrometry
by: Baige Cao, et al.
Published: (2025-01-01)

Amino Acid Signature of Oxidative Stress in Patients with Type 2 Diabetes: Targeted Exploratory Metabolomic Research
by: Cornelia G. Bala, et al.
Published: (2021-04-01)

Exploring the role of NLRP3 infalmmasome in diabetes: a literature review and bibliometric analysis
by: Yi Tan, et al.
Published: (2024-12-01)

Individual gut microbiological signature in obese diabetic spouses – case report and literature review
by: Magdalena Piłot, et al.
Published: (2024-02-01)

Diabetes, obesity, hypertension, and risk of severe COVID19: a protocol for systematic review and meta-analysis
by: Li, C, et al.
Published: (2021)

Diabetes, obesity, hypertension and risk of severe COVID-19: a protocol for systematic review and meta-analysis
by: Nazrul Islam, et al.
Published: (2021-11-01)

In silico structure-based designers of therapeutic targets for diabetes mellitus or obesity: A protocol for systematic review.
by: Ana Francisca Teixeira Gomes, et al.
Published: (2022-01-01)